Bank v. New York State Department of Health

Background

John Doe filed a complaint challenging 10 NYCRR § 58-1.8, a New York State Department of Health regulation. He alleged that the regulation prevented him from obtaining certain laboratory-test results directly from the seller without involvement by a medical professional. He claimed that the regulation was preempted by federal law and therefore violated the Constitution’s Supremacy Clause.

The plaintiff filed the case as “John Doe” without first asking the court for permission to use a pseudonym. The court ordered him to explain why he should be allowed to proceed anonymously. He argued that discovery might reveal the type of medical tests he wished to take and make his personal medical concerns public. He did not identify the tests or allege that he faced retaliation if his identity became known. The defendants opposed anonymous litigation and argued that any sensitive laboratory information could instead be sealed or redacted.

Legal standard

Federal Rule of Civil Procedure 10(a) generally requires the parties to be named in the complaint’s title. The court explained that using a pseudonym is an exception to that rule. Under Second Circuit precedent, the court must balance the plaintiff’s interest in anonymity against the public interest in disclosure and any prejudice to the defendants.

The court considered ten factors, including the sensitivity of the matter, the risk of retaliation or other harm, the plaintiff’s vulnerability, whether the lawsuit challenged government action, possible prejudice to the defendants, whether the identity had remained confidential, the public interest in knowing the plaintiff’s identity, the legal nature of the dispute, and alternative ways to protect confidential information.

Court’s analysis

The court found that most factors favored disclosure. The plaintiff had not identified the medical tests or provided specific facts showing that the subject matter was sufficiently sensitive and personal. The parties agreed that there was no risk of retaliation, and the plaintiff had not alleged other harms beyond speculative and conclusory concerns. He also made no allegations that his age made him especially vulnerable.

Three factors favored anonymity to some degree. The lawsuit challenged government action rather than private conduct. The defendants had not shown that they would be prejudiced because they could evaluate the plaintiff’s evidence without knowing his name, and the plaintiff said he was willing to disclose his identity to the other parties. The plaintiff’s identity had also remained confidential.

The court nevertheless concluded that these considerations did not overcome the public interest in disclosure. Knowing the plaintiff’s identity could help the public assess whether the lawsuit was brought independently or was supported by commercial or other interest groups. The court also found that the case’s legal nature did not make the public interest in the parties’ identities unusually weak. Finally, the court emphasized that redaction, sealing, a protective court order, or a confidentiality agreement could protect sensitive medical information without allowing the plaintiff to remain anonymous.

Disposition

After balancing the interests of the plaintiff, defendants, and public, the court concluded that this case was not exceptional enough to justify pseudonymous litigation. Judge Gregory H. Woods denied the plaintiff’s application to proceed pseudonymously. The court directed the plaintiff to file an amended complaint within seven days from the date of the order. The opinion addressed only the plaintiff’s ability to litigate anonymously; it did not decide the underlying federal-preemption challenge to the New York regulation.